Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?

Walree, Inez Charlotte van; Hamaker, Marije E.; Rooij, Belle H. de; Boll, Dorry; Huis‐Tanja, Lieke H. van; Emmelot-Vonk, Mariëlle H.; Ezendam, Nicole P. M.

doi:10.1016/j.jgo.2020.02.012

Cited by 8 publications

(2 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[26], with 73.9% of patients at stages I and II, and the rest of the group studied in his report (stages III and IV) accounting for 26.1%, as well as by Helpman et al [27], who in their large study of more than 20,000 patients with endometrial cancer describe that 73% of tumours were confined to the uterus, so the stage was I or II. A slightly different cross-section of tumour progression was obtained by Van Walree et al [28], who report that FIGO stage I patients comprise as many as 88% of the study participants, while stage II patients comprise only 3%.…”

Section: Discussionmentioning

confidence: 73%

Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 73%

Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In ECS the co-morbidity burden is greater than with other histological types as age-related deterioration in health-related QOL can be more prevalent as diagnosis is usually made in over 65s [88,89]. Additionally, as stated earlier, in older individuals the potential for hypertrophic changes following RT is diminished [81].…”

Section: Cancer Histology Resistance Training and Cancer-related Fatiguementioning

confidence: 94%

Twentieth-Century Gothic

Armitt¹

2022

View full text Add to dashboard Cite

Purpose: Cancer-related fatigue (CRF) is unrelenting. As neither rest nor sleep ameliorates cognitive, emotional, and physical symptoms, quality of life is diminished. This study examines resistance training (RT) effectiveness on CRF in cancer survivors. The secondary aims were to identify the dose-response relationship of RT frequency, intensity, and volume on CRF in different cancer survivor populations. Materials and methods: Systematic searches via numerous databases for RCTs were performed in June 2022. Patient-reported outcome measures (PROM), were analysed, pre-to-post intervention, using a random-effects model. The Physiotherapy Evidence Database (PEDro) scale informed methodological quality assessment. Results: Eight studies were included (cancer survivors: breast (BCS) = 5; endometrial (ECS) = 1; prostate (PCS) = 2). Overall, RT interventions ≥ 6 weeks elicited large significant reductions in CRF for FACIT-F (SMD = 0.932, p = <0.001) and moderate significant reductions in CRF for PFS-R (SMD = −0.622, p = 0.004). Conclusion:Main findings indicate that RT ameliorates CRF, especially in BCS; however, individualised approaches should be advocated. Supervised training elicited the greatest positive outcomes, thus should be a pivotal part of the cancer rehabilitation pathway. Future studies should be adequately powered, undertake discrete analyses of different cancer types, and investigate chronic RT effects. h IMPLICATIONS FOR REHABILITATION • Cancer-related fatigue (CRF) is debilitating and distressing, leading to reduced quality of life and function in cancer survivors. • Considerable heterogeneity exists in disease histology and clinical patient presentation. • Individualised resistance training (RT) is an effective, safe, and accessible intervention to mitigat:e fatigue levels, thus aid function, most notably in breast cancer survivors

show abstract

Postoperative health-related quality of life of patients with gynecological malignancy: a meta-analysis

Deng

Xing

et al. 2021

Support Care Cancer

View full text Add to dashboard Cite

Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?

Cited by 8 publications

References 38 publications

Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?

Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?

Twentieth-Century Gothic

Postoperative health-related quality of life of patients with gynecological malignancy: a meta-analysis

Contact Info

Product

Resources

About